Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target
Nadia Alice Vieira Motta, Lis Jappour Autran, Stephani Correia Brazão, Rosane de Oliveira Lopes, Christianne Brêtas Vieira Scaramello, Gabriel Ferreira Lima, Fernanda Brito
Topics & Concepts
CilostazolDrug repositioningMedicinePharmacologyDrugPhosphodiesterase inhibitorCoronavirusDiseaseCoronavirus disease 2019 (COVID-19)AspirinInfectious disease (medical specialty)Internal medicineCOVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsPiperaceae Chemical and Biological Studies